Pfizer shares slump 3.60% on fourth quarter loss, lower 2026 outlook
Pfizer highlighted another fall in quarterly revenues tied to Covid-19 products, and $4.4 billion in asset impairments
Pfizer highlighted another fall in quarterly revenues tied to Covid-19 products, and $4.4 billion in asset impairments
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
